These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 1386018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G, Li Vecchi M, Mulé G, Cottone S, Mangano MT, Andronico G, Contomo A, Parrino IA, Renda F, Pavone G, Scialabba A.
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F, Williams O, Chapman A.
    Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
    [Abstract] [Full Text] [Related]

  • 6. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB, Gabow PA.
    Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
    [No Abstract] [Full Text] [Related]

  • 7. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
    Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P.
    Kidney Int; 1994 Oct; 46(4):1118-23. PubMed ID: 7861706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR, Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypertension, lipid abnormalities and cardiovascular changes in autosomal dominant polycystic kidney disease.
    Polat H, Karayaylali I, Niyazova Z, Seyrek N, Paydaş S, Sagliker Y.
    Nephron; 1998 Sep; 78(3):369-71. PubMed ID: 9546713
    [No Abstract] [Full Text] [Related]

  • 12. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
    Engeli S, Sharma AM.
    J Mol Med (Berl); 2001 Sep; 79(1):21-9. PubMed ID: 11327100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T, Schrier RW.
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G, Vecchi M, Mulè G, Cottone S, Mangano MT, Andronico G, Contorno A, Parrino I, Renda F, Pavone G.
    Am J Nephrol; 1998 May; 18(5):391-8. PubMed ID: 9730562
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.